Mesenchymal stem cells are multipotent stromal stem cells that can differentiate to any kind of cells like bone, cartilage, adipose, muscles, and neural cells. Mesenchymal stem cells can be derived from different tissues such as bone marrow, dental pulp, adipose tissues, and umbilical cord. But the human umbilical cord is the rich source of mesenchymal stem cells that are usually collected at the birth of a child, are being used in the treatment of auto-immune disease and also for treating diseases of the blood. In the past, most of the diseases were used to treat by the transplantation of organs or by embryonic stem cells. But transplantation of organs usually carries the risk of organ rejection and the other major drawback of this treatment is the unavailability of the proper donor. And if we use pre-specialized will produce only specific cells. While in umbilical cord therapy, we use stem cells that are not pre-specialized. The hUCMSCs are being used in the cochlea to repair sensorineural hearing, they are being used for the treatment of the corneal diseases, liver cirrhosis, liver fibrosis, diabetes mellitus, dilated cardiopathy, neurodegenerative diseases, joint pathologies, radiation-induced lung injury, and periventricular leukomalacia. The umbilical cord mesenchymal stem cells can be obtained from umbilical cord blood that contains hematopoietic stem cells, and also from Wharton’s jelly, cord lining, perivascular region. The purpose of this study is to evaluate the use of hUCMSCs for treatment of a different type of blood, immune system, neurodegenerative disease, and to check the effect of pigment epithelium-derived factor on hUCMSCs and effect of hexachlorophene on hUCMSCs.

Keywords: hUCMSCs, Liver cirrhosis, stem cell therapy, diabetes mellitus.

Lu LL, Liu YJ, Yang SG, Zhao QJ, Wang X, Gong W, et al. Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials. Haematologica. 2006;91(8):1017-26.

Nicodemou A, Danisovic L. Mesenchymal stromal/stem cell separation methods: concise review. Cell and tissue banking. 2017;18(4):443-60.

Bieback K, Netsch P. Isolation, Culture, and Characterization of Human Umbilical Cord Blood-Derived Mesenchymal Stromal Cells. Methods in molecular biology (Clifton, NJ). 2016;1416:245-58.

Ding DC, Chang YH, Shyu WC, Lin SZ. Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy. Cell transplantation. 2015;24(3):339-47.

Weiss ML, Medicetty S, Bledsoe AR, Rachakatla RS, Choi M, Merchav S, et al. Human umbilical cord matrix stem cells: preliminary characterization and effect of transplantation in a rodent model of Parkinson's disease. Stem cells (Dayton, Ohio). 2006;24(3):781-92.

Stanko P, Kaiserova K, Altanerova V, Altaner C. Comparison of human mesenchymal stem cells derived from dental pulp, bone marrow, adipose tissue, and umbilical cord tissue by gene expression. Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia. 2014;158(3):373-7.

Ma Y, Guo W, Yi H, Ren L, Zhao L, Zhang Y, et al. Transplantation of human umbilical cord mesenchymal stem cells in cochlea to repair sensorineural hearing. American journal of translational research. 2016;8(12):5235-45.

Ziaei M, Zhang J, Patel DV, McGhee CNJ. Umbilical cord stem cells in the treatment of corneal disease. Survey of ophthalmology. 2017;62(6):803-15.

Sang W, Lv B, Li K, Lu Y. Therapeutic efficacy and safety of umbilical cord mesenchymal stem cell transplantation for liver cirrhosis in Chinese population: A meta-analysis. Clinics and research in hepatology and gastroenterology. 2018;42(3):193-204.

Oyagi S, Hirose M, Kojima M, Okuyama M, Kawase M, Nakamura T, et al. Therapeutic effect of transplanting HGF-treated bone marrow mesenchymal cells into CCl4-injured rats. Journal of hepatology. 2006;44(4):742-8.

Xu LN, Lin N, Xu BN, Li JB, Chen SQ. Effect of human umbilical cord mesenchymal stem cells on endometriotic cell proliferation and apoptosis. Genetics and molecular research : GMR. 2015;14(4):16553-61.

Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418(6893):41-9.

El-Badri N, Ghoneim MA. Mesenchymal stem cell therapy in diabetes mellitus: progress and challenges. Journal of nucleic acids. 2013;2013:194858.

Tombran-Tink J, Chader GG, Johnson LV. PEDF: a pigment epithelium-derived factor with potent neuronal differentiative activity. Experimental eye research. 1991;53(3):411-4.

Ha CW, Park YB, Chung JY, Park YG. Cartilage Repair Using Composites of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells and Hyaluronic Acid Hydrogel in a Minipig Model. Stem cells translational medicine. 2015;4(9):1044-51.

Li W, Li K, Gao J, Yang Z. Autophagy is required for human umbilical cord mesenchymal stem cells to improve spatial working memory in APP/PS1 transgenic mouse model. Stem cell research & therapy. 2018;9(1):9.

Ding DC, Wen YT, Tsai RK. Pigment epithelium-derived factor from ARPE19 promotes proliferation and inhibits apoptosis of human umbilical mesenchymal stem cells in serum-free medium. Experimental & molecular medicine. 2017;49(12):e411.

Lesniak M, Zdanowski R, Suska M, Brewczynska A, Stankiewicz W, Kloc M, et al. Effects of Hexachlorophene, a Chemical Accumulating in Adipose Tissue, on Mouse and Human Mesenchymal Stem Cells. Tissue engineering and regenerative medicine. 2018;15(2):211-22.

Arufe MC, De la Fuente A, Fuentes I, Toro FJ, Blanco FJ. Umbilical cord as a mesenchymal stem cell source for treating joint pathologies. World journal of orthopedics. 2011;2(6):43-50.

Zhang W, Wang Y, Kong J, Dong M, Duan H, Chen S. Therapeutic efficacy of neural stem cells originating from umbilical cord-derived mesenchymal stem cells in diabetic retinopathy. Scientific reports. 2017;7(1):408.

Xue J, Li X, Lu Y, Gan L, Zhou L, Wang Y, et al. Gene-modified mesenchymal stem cells protect against radiation-induced lung injury. Molecular therapy : the journal of the American Society of Gene Therapy. 2013;21(2):456-65.

Yao Y, Zheng Z, Song Q. Mesenchymal stem cells: A double-edged sword in radiation-induced lung injury. Thoracic cancer. 2018;9(2):208-17.

Xiang GA, Zhang GQ, Fang CH, Gao P, Chen KY. [A preliminary study of the homing capacity of allograft mesenchymal stem cells to rat liver]. Di 1 jun yi da xue xue bao = Academic journal of the first medical college of PLA. 2005;25(8):994-7.

Yang H, Xie Z, Wei L, Yang H, Yang S, Zhu Z, et al. Human umbilical cord mesenchymal stem cell-derived neuron-like cells rescue memory deficits and reduce amyloid-beta deposition in an AbetaPP/PS1 transgenic mouse model. Stem cell research & therapy. 2013;4(4):76.

Zhang GZ, Sun HC, Zheng LB, Guo JB, Zhang XL. In vivo hepatic differentiation potential of human umbilical cord-derived mesenchymal stem cells: Therapeutic effect on liver fibrosis/cirrhosis. World journal of gastroenterology. 2017;23(46):8152-68.